Hospitals | November 02, 2025
Medanta Super Speciality Hospital to set up new hospital in Guwahati
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
The upcoming state-of-the art 400+ bed facility is set to come up at an approximate cost of Rs 500 crore
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody to demonstrate a complete renal response benefit in lupus nephritis in a randomised phase III study
Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Datroway becomes the first and only therapy to show overall survival benefit versus chemotherapy in this difficult-to-treat patient population
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
